Effectiveness of ACE Inhibitors and ARBs in Diabetic Kidney Disease

This chapter explores a Cochrane review analyzing the role of ACE inhibitors and ARBs in preventing end-stage kidney disease among patients with diabetic kidney disease. It highlights the potential benefits of ARBs for kidney outcomes while noting the limited impact on mortality and the low certainty of evidence.